Approval · Notice of Compliance 16104 · 2014
LINCOMIX 100: Notice of Compliance 16104
Issued September 18, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16104
- Date
- September 18, 2014
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing, packaging and testint site
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LINCOMIX 100 | 00813745 | Marketed |
Medicinal ingredients
- LINCOMYCIN HYDROCHLORIDE 100 MG per ML